Get an overview of Novozymes' share price development and analyze the performance, or read about Novozymes' ownership structure.
The A common stock is held by Novo A/S, which is wholly owned by the Novo Nordisk Foundation. In addition, at the end of 2014, Novo A/S held 27,779,900 B shares. Altogether this gave Novo A/S 26% of the total common stock and 70% of the votes.
Read more about Novozymes' ownership structure here.